Results 101 to 110 of about 160,800 (350)

Evaluation of an oral telomerase activator for early age-related macular degeneration - a pilot study

open access: yesClinical Ophthalmology, 2016
Coad Thomas Dow,1,2 Calvin B Harley3 1McPherson Eye Research Institute, University of Wisconsin-Madison, Madison, WI, USA; 2Chippewa Valley Eye Clinic, Eau Claire, Wisconsin, WI, USA; 3Independent Telomere Biology Consultant, Murphys, CA, USA Purpose ...
Dow CT, Harley CB
doaj  

Anemia and retinopathy of prematurity: A narrative review

open access: yesPediatric Investigation, EarlyView.
Anemia in infants who are at greatest risk of developing severe retinopathy of prematurity is almost universal. There is plausible evidence in the literature correlating anemia with severe ROP. However, the relationship is complex, and further study is needed to better understand the potential molecular mechanisms for anemia‐associated ROP.
Minali Prasad   +3 more
wiley   +1 more source

Advances in the management of macular degeneration [PDF]

open access: yesF1000Prime Reports, 2014
Current management of age-related macular degeneration (AMD) can be divided into two categories: first, anti-vasoendothelial growth factor (anti-VEGF) injection for wet macular degeneration; second, anti-oxidant vitamins for dry macular degeneration.
openaire   +3 more sources

Application of artificial intelligence in myopia prevention and control

open access: yesPediatric Investigation, EarlyView.
Current applications of artificial intelligence (AI) in the field of myopia prevention and control were comprehensively reviewed. Challenges, current development status, and future directions of AI have also been discussed, holding great significance for the further application of AI in myopia management.
Nan Liu, Li Li, Jifeng Yu
wiley   +1 more source

Nanoparticle Therapeutics in Clinical Perspective: Classification, Marketed Products, and Regulatory Landscape

open access: yesSmall, EarlyView.
This review presents a detailed overview of clinically approved nanoparticle therapeutics, classifying them by type and discussing their unique advantages in drug delivery. It highlights regulatory challenges across global markets and emphasizes the need for adaptive approval pathways.
Nimeet Desai   +5 more
wiley   +1 more source

Effectiveness of treatment of exudative age-related macular degeneration with anti-vascular endothelial growth factor drugs [PDF]

open access: yesRevista Brasileira de Oftalmologia
Objective: To characterize the effectiveness of anti-vascular endothelial growth factor drugs in exudative age-related macular degeneration. Methods: Retrospective longitudinal study of 54 patients with age-related macular degeneration receiving ...
Raquel Coelho de Souza Lima Melo   +5 more
doaj   +1 more source

Experimental and Computational Insights into the Structural Dynamics of the Fc Fragment of IgG1 Subtype from Biosimilar VEGF‐Trap

open access: yesSmall Structures, EarlyView.
The constant fragment (Fc) of the immunoglobulin G1 (IgG1) subtype is a widely used scaffold for designing advanced therapeutics. Herein, together with the integration of experimental and computational techniques, this study reveals the structural dynamics of the N‐glycan‐bound Fc fragment of IgG1 from VEGF‐Trap, providing a new insight into enhancing ...
Ebru Destan   +11 more
wiley   +1 more source

Macular Pigment and Visual Function in Patients With Glaucoma: The San Diego Macular Pigment Study. [PDF]

open access: yes, 2018
PurposeAlthough recent studies have shown that macular pigment (MP) is significantly lower in glaucoma patients, this relationship merits further investigation.MethodsThis cross-sectional study included 85 glaucoma patients and 22 controls.
Daga, Fábio B   +7 more
core  

Home - About - Disclaimer - Privacy